Oxygenta Pharmaceutical Limited (BOM:524636)

Market Cap	1.83B -30.1%
Revenue (ttm)	1.35B +20.9%
Net Income	-135.69M
EPS	-3.67
Shares Out	36.98M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	47,862
Open	51.41
Previous Close	50.81
Day's Range	48.56 - 51.41
52-Week Range	43.00 - 74.00
Beta	0.76
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2026

About Oxygenta Pharmaceutical

Oxygenta Pharmaceutical Limited manufactures and sells pharmaceutical, medical, and veterinary preparations in India and internationally. It offers active pharmaceuticals ingredients, commercial intermediates, and organic fine chemicals, as well as formulations. The company was formerly known as S.S. Organics Limited and changed its name to Oxygenta Pharmaceutical Limited in February 2022. Oxygenta Pharmaceutical Limited was incorporated in 1990 and is based in Hyderabad, India. Oxygenta Pharmaceutical Limited operates as a subsidiary of Virupa...

• Industry: Pharmaceutical Preparations
• Founded: 1990
• Employees: 170
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524636

Financial Performance

In fiscal year 2026, Oxygenta Pharmaceutical's revenue was 1.13 billion, an increase of 2.39% compared to the previous year's 1.11 billion. Losses were -175.72 million, 70.6% more than in 2025.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 27, 2026

Data Sources Report a data error